Home > NRC Library > ADAMS Public Documents

06-27843-02 592604 Bristol-Myers Squibb Pharmaceutical Research Institute.

Accession Number: ML16363A312

Date Released: Friday, March 10, 2017

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML16363A313 - Bristol-Myers Squibb PRI, Amendment Request NRC Form 313 dated 12/15/16. (8 page(s), 12/15/2016)
• ML17060A275 - Bristol-Myers Squibb PRI, E-mail dtd February 24, 2017, RE: Deficiency Request, Control No. 592604. (2 page(s), 2/24/2017)
• ML17060A293 - Bristor-Myers Squibb PRI, E-mail dtd February 27, 2017, RE: Deficiency Response, Control No. 592604. (1 page(s), 3/27/2017)
• ML17060A316 - Bristol-Myers Squibb PRI, Cover Letter dtd February 22, 2017, for License Amendment No. 22, Control No. 592604. (3 page(s), 2/22/2017)
• ML17061A156 - Bristol-Myers Squibb Pharmaceutical Research Institute, License Amendment No. 22, Control No. 592604. (5 page(s), 2/22/2017)